Hoffmann, Christian, Schommers, Philipp ORCID: 0000-0003-3375-6800, Wolf, Eva, Mueller, Markus, Schultze, Alexander, Krznaric, Ivanka, Stoehr, Albrecht, Wolf, Timo, Faektenheuer, Gerd, Stier, Bastian, Wyen, Christoph and Hentrich, Marcus (2016). CD4(+) and CD8(+) T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma. Aids, 30 (5). S. 753 - 761. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1473-5571

Full text not available from this repository.

Abstract

Objective: The risk of non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) is increased in HIV-infected individuals. We studied the kinetics of lymphocyte subsets in patients who subsequently developed HL or NHL while on virologically suppressive antiretroviral therapy (ART). Design: Using a nested case-control design, cases of HIV+ HL or NHL were selected from two prospective clinical studies. Aviremia was defined as less than 200 HIV-RNA copies/ml for at least 6 months prior to lymphoma diagnosis. Each case was matched to three aviremic HIV+ controls without lymphoma. Results: In the 81 cases (50 HL and 31 NHL), prediagnostic CD4(+) T cells and CD8(+) T cells displayed discordant kinetics compared with controls. Within the last and within the next-to-last year preceding HL diagnosis, mean CD4(+) T cells decreased by -168 and by -2 cells/mu l, compared with an increase of +44 and +73 cells/mu l in the controls, respectively. Mean CD8(+) T cells decreased by -352 and -115 cells/mu l, compared with nonsignificant changes of -29 and +/- 0 cells/mu l in the controls, respectively. T-cell kinetics demonstrated a marked inter-individual variability. Kinetics of CD4(+) and CD8(+) T cells were also discordant between NHL cases and controls. Conclusion: This study on a large number of aviremic patients developing HL and NHL who were carefully matched with controls, gives insights to prediagnostic kinetics of immune parameters. The discordant kinetics of both CD4(+) and CD8(+) T cells are already seen 1-2 years prior to lymphoma diagnosis, are more pronounced during the last year and in patients developing HL but are also seen in NHL.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Hoffmann, ChristianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schommers, PhilippUNSPECIFIEDorcid.org/0000-0003-3375-6800UNSPECIFIED
Wolf, EvaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mueller, MarkusUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schultze, AlexanderUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Krznaric, IvankaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stoehr, AlbrechtUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wolf, TimoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Faektenheuer, GerdUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stier, BastianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wyen, ChristophUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hentrich, MarcusUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-281498
DOI: 10.1097/QAD.0000000000000980
Journal or Publication Title: Aids
Volume: 30
Number: 5
Page Range: S. 753 - 761
Date: 2016
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Place of Publication: PHILADELPHIA
ISSN: 1473-5571
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
PERIPHERAL-BLOOD; UNITED-STATES; RISK; COHORT; INDIVIDUALS; DISEASE; CANCER; IMMUNODEFICIENCY; MICROENVIRONMENT; MULTICENTERMultiple languages
Immunology; Infectious Diseases; VirologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/28149

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item